🇺🇸 FDA
Patent

US 7767717

Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

granted A61KA61K31/135A61K31/138

Quick answer

US patent 7767717 (Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen) held by Northwestern University expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/135, A61K31/138, A61K47/10, A61K47/38